The pharmaceutical industry had to wait more than five years for FDA's Office of Prescription Drug Promotion (OPDP) to finally publish the guidance document "Internet/Social Media Platforms: Correcting Independent Third-party Misinformation About Prescription Drugs and Medical Devices" on June 18, 2014.
This article reviews the FDA's guidance on how pharmaceutical companies can respond to misinformation related to a firm's own FDA-approved or -cleared products when that information is created or disseminated by independent third parties on the Internet or through social media, regardless of whether that misinformation appears on a firm's own forum or an independent third-party forum or website.
Topics include (partial list)
Download the full text PDF file here:
- Hosting Online Discussions
- FDA Recommendations
- Correcting Wikipedia Misinformation
- The Freedom to Be Ignored
- Should Pharma Correct Misinformation on Wikipedia?